(Q34756070)

4 August 2017

1 reference

title

Hepatocellular carcinoma: predisposing conditions and precursor lesions (English)

1 reference

4 August 2017

main subject

hepatocellular carcinoma

1 reference

2

Elizabeth M Brunt

1 reference

4 August 2017

Marie Ann Bailey

1

1 reference

4 August 2017

publication date

1 June 2002

1 reference

Gastroenterology Clinics of North America

4 August 2017

published in

1 reference

4 August 2017

volume

31

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

641-662

1 reference

Epidemiology of hepatocellular carcinoma

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Hepatocellular carcinoma in the developing world

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Prevalence of hepatitis B in selected Alaskan Eskimo villages

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Pathogenesis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

1 reference

7 January 2021

Screening for cancer in viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Proliferating cell nuclear antigen in hepatocellular carcinoma and small cell liver dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Liver cell dysplasia: a premalignant condition

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Small encapsulated hepatocellular carcinoma of the liver. Provisional analysis of pathogenetic mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Premalignant lesions of hepatocellular carcinoma: pathologic viewpoint

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Liver cell atypias: a comparative study in cirrhosis with and without hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Macroregenerative nodules and hepatocellular carcinoma in forty-four sequential adult liver explants with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Low proliferative activity in macroregenerative nodules: evidence for an alternate hypothesis concerning human hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Proliferating cell nuclear antigen and Ki-67 labeling in hepatocellular nodules: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Small hepatocellular carcinoma: its relationship to multistep hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Irregular regeneration of hepatocytes is an important factor in the hepatocarcinogenesis of liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Morphologic studies of the liver cell dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Ultrasonography-detected macroregenerative nodules in cirrhosis: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Histological features and clinical course of large regenerative nodules: Evaluation of their precancerous potentiality

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Clonal analysis of hepatocellular carcinoma and dysplastic nodule by methylation pattern of X-chromosome-linked human androgen receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Clonal analysis of macronodules in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Clonality of large regenerative nodules in liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Clonal expansion in evolution of chronic hepatitis to hepatocellular carcinoma as seen at an X-chromosome locus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Hepatocellular carcinoma: molecular biology of its growth and relationship to hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Hepatitis B virus and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Relative risk for the development of hepatocellular carcinoma in alcoholic patients with cirrhosis: a multiple logistic-regression coefficient analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Nonalcoholic steatohepatitis: An expanded clinical entity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Large-cell change of hepatocytes in cirrhosis may represent a reaction to prolonged cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Hemochromatosis: diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Iron as a hepatotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

p53 mutations in british patients with hepatocellular carcinoma: clustering in genetic hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Interaction between haemochromatosis and transferrin receptor genes in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Liver injury in alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Diffuse hepatocellular dysplasia and carcinoma associated with the Mmalton variant of alpha 1-antitrypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Liver carcinoma in PiZ alpha-1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

An international symposium on Wilson's and Menkes' diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

1 reference

7 January 2021

Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Nonalcoholic steatohepatitis: a study of 49 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Nonalcoholic Steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites: the Paris Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Hepatocellular carcinoma arising in non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Type la glycogenosis associated with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Adenomas in glycogen storage disease type 1. Two cases with unusual histologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Screening for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Clinical, virologic, and pathologic significance of elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Serum des-gamma-carboxyprothrombin concentration determined by the avidin-biotin complex method in small hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Diagnosis of hepatocellular carcinoma by concanavalin A affinity electrophoresis of serum alpha-fetoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Detection of hepatocellular carcinoma-specific alpha-fetoprotein by isoelectric focusing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

'Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Clinical usefulness of des-?-carboxy prothrombin assay in early diagnosis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Diagnosis of hepatocellular carcinoma by quantitative detection of hepatoma-specific bands of serum gamma-glutamyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

The value of serum tissue polypeptide specific antigen in the diagnosis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Imaging evaluation of the cirrhotic liver

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Detection of hepatocellular carcinoma in cirrhotic patients: sensitivity of CT and ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Imaging of hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Radiologic diagnosis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Characterization of focal hepatic lesions with duplex sonography: findings in 198 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Hepatocellular carcinoma: are combined CT during arterial portography and CT hepatic arteriography in addition to triple-phase helical CT all necessary for preoperative evaluation?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Hepatocellular carcinoma: the role of helical biphasic contrast-enhanced CT versus CT during arterial portography

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Using triphasic helical CT to detect focal hepatic lesions in patients with neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Small Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

MR imaging during arterial portography for assessment of hepatocellular carcinoma: comparison with CT during arterial portography

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Diaphragmatic and subcutaneous seeding of hepatocellular carcinoma following fine-needle aspiration biopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Small hepatocellular carcinoma: differentiation from adenomatous hyperplastic nodule with color Doppler flow imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

Nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900017-1

7 January 2021

10.1016/S0889-8553(02)00017-1

Identifiers

DOI

1 reference

4 August 2017

1 reference